New diabetes clinical trial: Tailoring Obesity Treatment Trial

Published on: September 29, 2024 at 11:00PM
Conditions: Obesity; Appetite Regulation; PreDiabetes
Interventions: Drug: Pramlintide Acetate 1 MG/ML; Drug: Semaglutide Pen Injector; Drug: Sodium Chloride 0.9% Inj
Sponsors: Esbjerg Hospital - University Hospital of Southern Denmark
Not yet recruiting
https://ift.tt/XmIa8p4